GSK introduces Children's Flonase Allergy Relief

WARREN, N.J. - GlaxoSmithKline on Tuesday announced the official launch of its Children's Flonase Allergy Relief. 

 

Available without a prescription, Children's Flonase is an over-the-counter nasal spray approved to offer relief of allergy symptoms including runny nose, sneezing, itchy nose, congestion and itchy, watery eyes. Children's Flonase is a safe, non-habit forming way for children ages four and older to get relief from their nose- and eye-related allergy symptoms. Its active ingredient, fluticasone propionate, has been the No. 1 pediatrician-prescribed nasal allergy medicine for over five years.

 

Over the past 20 years, the number of children suffering from allergies has doubled, and reports show that allergies now affect an estimated 40% of children nationwide. A recent survey commissioned by GSK revealed that a majority of parents of young children with seasonal allergies tend to limit their children's time outdoors during allergy season. 

 

The survey of more than 1,000 parents of children (ages 4-11) with allergies provides insights into the challenges of helping to manage their children's symptoms. The results found that 67% of parents have limited their child's time outside during allergy season, and with so many treatment options, 38% of parents said they find it difficult to pick an over-the-counter allergy medicine.

 

Children's Flonase works differently from single-ingredient antihistamines, because it blocks six allergic substances instead of just one, GSK noted. It reduces inflammation and relieves allergy symptoms caused by pollen, mold spores, dust mites and pet dander.